Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test measures your International Normalized Ratio after neutralizing the effect of heparin in the blood sample. The INR is derived from the prothrombin time and reflects how quickly your blood forms a clot through the pathway that depends on vitamin K–related clotting factors. Heparin can falsely prolong this clotting test when it contaminates the sample or when you are receiving heparin therapy. By neutralizing heparin before analysis, the result better represents your true INR.
It is typically used when there is concern that heparin exposure has affected a standard INR result, such as when blood is drawn from a line that has been flushed with heparin or when you are transitioning between anticoagulants.
Accurate INR results guide decisions about procedures, bleeding risk, and dosing of vitamin K antagonists. If heparin is present in the sample, the INR may appear higher than it really is, which can lead to unnecessary delays or changes in treatment. A heparin adjusted INR helps confirm whether a prolonged result is genuine or due to sample contamination or ongoing heparin therapy.
Clinicians may order this test when a prolonged INR is unexpected, when results conflict with your clinical picture, or during transitions between heparin and warfarin. Clarifying the true INR can prevent inappropriate dose changes, reduce safety risks, and support timely care.
If the INR remains elevated after heparin neutralization, it suggests a true effect on clotting such as warfarin activity, low vitamin K, liver dysfunction, or certain factor deficiencies. If the INR normalizes after neutralization, the prior prolonged result was likely due to heparin in the sample rather than a true problem with your clotting system.
Your clinician will interpret the result alongside your medications, medical history, and other tests such as prothrombin time, activated partial thromboplastin time, or anti factor Xa levels. Depending on the context, they may repeat testing with careful sample collection, adjust medications, or investigate for conditions that affect clotting. Do not change or stop any anticoagulant on your own; discuss next steps with your care team.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Blood drawn from a catheter or line that was flushed with heparin can contaminate the sample and falsely prolong the INR. Using a peripheral stick or discarding an adequate waste volume reduces this effect.
Unfractionated heparin, low molecular weight heparin, direct oral anticoagulants, and warfarin can each affect clotting tests. Heparin neutralization minimizes heparin’s impact, but other drugs may still influence the INR.
Low vitamin K intake, poor absorption, or antibiotics that alter gut flora can lower vitamin K–dependent factors and raise the INR. Sudden changes in diet or supplements can also shift results.
The liver makes most clotting proteins measured by the INR. Liver disease or acute injury can increase the INR independent of medications, even after heparin is neutralized.
Hemolysis, high bilirubin, or very cloudy plasma can interfere with clot detection systems. Prompt, proper mixing of the tube and testing within recommended time frames improve accuracy.
During overlap of heparin and warfarin, interpretation can be complex. A heparin adjusted INR helps clarify when warfarin is therapeutic and whether it is safe to stop heparin.
References